Nippon Chemiphar Co., Ltd. (4539.T)
JPY 1512.0
(-0.13%)
JPY 1512.0
(-0.13%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 13.34 Billion JPY | 10.18% |
| 2022 | 12.11 Billion JPY | 5.0% |
| 2021 | 11.53 Billion JPY | -7.57% |
| 2020 | 12.47 Billion JPY | 4.56% |
| 2019 | 11.93 Billion JPY | -5.23% |
| 2018 | 12.59 Billion JPY | 5.24% |
| 2017 | 11.96 Billion JPY | -1.68% |
| 2016 | 12.17 Billion JPY | 32.97% |
| 2015 | 9.15 Billion JPY | -5.36% |
| 2014 | 9.67 Billion JPY | 8.38% |
| 2013 | 8.92 Billion JPY | 15.7% |
| 2012 | 7.71 Billion JPY | -6.09% |
| 2011 | 8.21 Billion JPY | 13.6% |
| 2010 | 7.23 Billion JPY | -8.37% |
| 2009 | 7.89 Billion JPY | 26.12% |
| 2008 | 6.25 Billion JPY | 126.34% |
| 2007 | 2.76 Billion JPY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 14.01 Billion JPY | 4.99% |
| 2024 Q2 | 14.42 Billion JPY | 2.93% |
| 2023 FY | 13.34 Billion JPY | 10.18% |
| 2023 Q2 | 13.72 Billion JPY | -2.76% |
| 2023 Q4 | 13.34 Billion JPY | -5.23% |
| 2023 Q1 | 14.11 Billion JPY | 16.51% |
| 2023 Q3 | 14.08 Billion JPY | 2.62% |
| 2022 Q2 | 12.67 Billion JPY | -3.1% |
| 2022 Q1 | 13.08 Billion JPY | 13.4% |
| 2022 Q3 | 12.32 Billion JPY | -2.73% |
| 2022 FY | 12.11 Billion JPY | 5.0% |
| 2022 Q4 | 12.11 Billion JPY | -1.76% |
| 2021 Q3 | 12.53 Billion JPY | -3.19% |
| 2021 FY | 11.53 Billion JPY | -7.57% |
| 2021 Q1 | 13.31 Billion JPY | 6.7% |
| 2021 Q2 | 12.94 Billion JPY | -2.77% |
| 2021 Q4 | 11.53 Billion JPY | -7.97% |
| 2020 Q2 | 13.21 Billion JPY | -0.84% |
| 2020 Q1 | 13.32 Billion JPY | 11.63% |
| 2020 Q3 | 12.76 Billion JPY | -3.39% |
| 2020 FY | 12.47 Billion JPY | 4.56% |
| 2020 Q4 | 12.47 Billion JPY | -2.23% |
| 2019 Q1 | 12.77 Billion JPY | 1.41% |
| 2019 Q2 | 13.15 Billion JPY | 2.98% |
| 2019 FY | 11.93 Billion JPY | -5.23% |
| 2019 Q4 | 11.93 Billion JPY | -5.99% |
| 2019 Q3 | 12.69 Billion JPY | -3.47% |
| 2018 Q2 | 13.12 Billion JPY | 4.27% |
| 2018 Q3 | 12.74 Billion JPY | -2.84% |
| 2018 FY | 12.59 Billion JPY | 5.24% |
| 2018 Q4 | 12.59 Billion JPY | -1.22% |
| 2018 Q1 | 12.58 Billion JPY | 5.16% |
| 2017 Q1 | 11.8 Billion JPY | -3.0% |
| 2017 Q4 | 11.96 Billion JPY | 0.93% |
| 2017 Q3 | 11.85 Billion JPY | -2.44% |
| 2017 Q2 | 12.15 Billion JPY | 2.94% |
| 2017 FY | 11.96 Billion JPY | -1.68% |
| 2016 Q1 | 8.93 Billion JPY | -2.41% |
| 2016 Q4 | 12.17 Billion JPY | 12.8% |
| 2016 Q3 | 10.79 Billion JPY | 1.05% |
| 2016 Q2 | 10.67 Billion JPY | 19.55% |
| 2016 FY | 12.17 Billion JPY | 32.97% |
| 2015 Q3 | 9.54 Billion JPY | -1.8% |
| 2015 FY | 9.15 Billion JPY | -5.36% |
| 2015 Q4 | 9.15 Billion JPY | -4.14% |
| 2015 Q2 | 9.72 Billion JPY | -2.05% |
| 2015 Q1 | 9.92 Billion JPY | 2.65% |
| 2014 Q2 | 10.03 Billion JPY | 5.81% |
| 2014 Q4 | 9.67 Billion JPY | -3.88% |
| 2014 FY | 9.67 Billion JPY | 8.38% |
| 2014 Q3 | 10.06 Billion JPY | 0.25% |
| 2014 Q1 | 9.48 Billion JPY | 6.3% |
| 2013 Q2 | 9.84 Billion JPY | 15.89% |
| 2013 Q3 | 9.49 Billion JPY | -3.55% |
| 2013 Q4 | 8.92 Billion JPY | -6.03% |
| 2013 FY | 8.92 Billion JPY | 15.7% |
| 2013 Q1 | 8.49 Billion JPY | 10.16% |
| 2012 Q1 | 8.5 Billion JPY | 3.6% |
| 2012 Q3 | 8.22 Billion JPY | -2.04% |
| 2012 Q2 | 8.4 Billion JPY | -1.28% |
| 2012 FY | 7.71 Billion JPY | -6.09% |
| 2012 Q4 | 7.71 Billion JPY | -6.27% |
| 2011 Q1 | 8.03 Billion JPY | 11.12% |
| 2011 Q4 | 8.21 Billion JPY | 3.27% |
| 2011 FY | 8.21 Billion JPY | 13.6% |
| 2011 Q3 | 7.95 Billion JPY | -1.74% |
| 2011 Q2 | 8.09 Billion JPY | 0.75% |
| 2010 Q3 | 7.59 Billion JPY | -3.24% |
| 2010 Q4 | 7.23 Billion JPY | -4.78% |
| 2010 FY | 7.23 Billion JPY | -8.37% |
| 2010 Q1 | 7.52 Billion JPY | -4.66% |
| 2010 Q2 | 7.84 Billion JPY | 4.32% |
| 2009 Q2 | 7.02 Billion JPY | 0.0% |
| 2009 Q4 | 7.89 Billion JPY | -4.7% |
| 2009 Q3 | 8.27 Billion JPY | 17.9% |
| 2009 FY | 7.89 Billion JPY | 26.12% |
| 2008 Q3 | 5.79 Billion JPY | 0.0% |
| 2008 Q4 | 6.25 Billion JPY | 8.01% |
| 2008 FY | 6.25 Billion JPY | 126.34% |
| 2007 FY | 2.76 Billion JPY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 1.23 Billion JPY | -983.997% |
| Takeda Pharmaceutical Company Limited | 4476.5 Billion JPY | 99.702% |
| Sumitomo Pharma Co., Ltd. | 133.36 Billion JPY | 89.995% |
| Shionogi & Co., Ltd. | 8.75 Billion JPY | -52.451% |
| Wakamoto Pharmaceutical Co.,Ltd. | - JPY | -Infinity% |
| Nippon Shinyaku Co., Ltd. | 1.15 Billion JPY | -1058.333% |
| Kaken Pharmaceutical Co., Ltd. | - JPY | -Infinity% |
| Eisai Co., Ltd. | 134.77 Billion JPY | 90.099% |
| Morishita Jintan Co., Ltd. | 106 Million JPY | -12488.679% |
| Hisamitsu Pharmaceutical Co., Inc. | 76 Million JPY | -17457.895% |
| Mochida Pharmaceutical Co., Ltd. | - JPY | -Infinity% |
| Fuso Pharmaceutical Industries,Ltd. | 7.02 Billion JPY | -90.058% |
| Tsumura & Co. | 54.37 Billion JPY | 75.46% |
| Kissei Pharmaceutical Co., Ltd. | - JPY | -Infinity% |
| Torii Pharmaceutical Co., Ltd. | 22 Million JPY | -60554.545% |
| Towa Pharmaceutical Co., Ltd. | 189.12 Billion JPY | 92.944% |
| Fuji Pharma Co., Ltd. | 11.92 Billion JPY | -11.909% |
| Zeria Pharmaceutical Co., Ltd. | 7.94 Billion JPY | -67.98% |
| KYORIN Holdings, Inc. | 435 Million JPY | -2967.586% |
| Taiko Pharmaceutical Co.,Ltd. | 2.74 Billion JPY | -386.83% |
| Daito Pharmaceutical Co.,Ltd. | 4.66 Billion JPY | -185.8% |
| SymBio Pharmaceuticals Limited | - JPY | -Infinity% |
| MedRx Co., Ltd | - JPY | -Infinity% |
| Mizuho Medy Co.,Ltd. | - JPY | -Infinity% |
| Solasia Pharma K.K. | 27 Million JPY | -49322.222% |
| Modalis Therapeutics Corporation | 412.5 Million JPY | -3134.909% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 4.5 Billion JPY | -196.204% |
| Sawai Group Holdings Co., Ltd. | 66.84 Billion JPY | 80.036% |
| Cyfuse Biomedical K.K. | 345 Million JPY | -3767.826% |
| Toho Holdings Co., Ltd. | 28.16 Billion JPY | 52.624% |
| Koa Shoji Holdings Co.,Ltd. | 1.59 Billion JPY | -738.515% |